- Report
- August 2022
- 119 Pages
Global
From €4275EUR$4,500USD£3,678GBP
- Report
- February 2023
- 221 Pages
Global
From €3026EUR$3,185USD£2,603GBP
€4323EUR$4,550USD£3,718GBP
- Report
- July 2021
- 111 Pages
Global
From €4228EUR$4,450USD£3,637GBP
- Report
- August 2020
- 85 Pages
Global
From €3800EUR$4,000USD£3,269GBP
- Report
- May 2023
- 119 Pages
Global
From €4275EUR$4,500USD£3,678GBP
- Report
- October 2023
- 91 Pages
Global
From €3500EUR$3,946USD£3,116GBP
- Report
- September 2023
- 93 Pages
Global
From €3500EUR$3,946USD£3,116GBP
- Report
- June 2023
- 87 Pages
Global
From €3500EUR$3,946USD£3,116GBP
- Report
- October 2023
- 146 Pages
Global
From €3351EUR$3,528USD£2,883GBP
€3943EUR$4,150USD£3,392GBP
- Report
- March 2020
- 107 Pages
Global
From €4275EUR$4,500USD£3,678GBP
The Elastomeric Infusion Pump market is a subset of the larger Infusions and Injectables market. Elastomeric Infusion Pumps are medical devices used to deliver fluids, such as medications, into a patient's body in a controlled manner. These pumps are typically used for long-term treatments, such as chemotherapy, antibiotics, and pain management. Elastomeric Infusion Pumps are designed to be lightweight and portable, allowing for easy transport and use in a variety of settings. They are also designed to be easy to use and maintain, making them a popular choice for healthcare providers.
Some of the major players in the Elastomeric Infusion Pump market include Baxter International, B. Braun Melsungen AG, Fresenius Kabi, Hospira, and Smiths Medical. Show Less Read more